Beta-adrenoceptors (b 2 -ARs) have beneficial effects on prefrontal cortex (PFC) working memory, however, the cellular and molecular mechanisms are unclear yet. In this study, we probed the effect of b 2 -AR-selective agonist clenbuterol (Clen) on synaptic transmission in layer 5/6 pyramidal neurons of PFC. Bath application of Clen reduced spontaneous IPSC (sIPSC) frequency without effects on sEPSCs. Clen did not alter the frequency and amplitude of miniature IPSCs (mIPSCs), but exerted heterogeneous effects on evoked IPSCs (eIPSCs) recorded from PFC layer 5/6 pyramidal neurons. Clen decreased the firing rate of action potentials of fast-spiking GABAergic interneurons. Clen-induced hyperpolarization of fast-spiking GABAergic interneurons required potentiation of an inward rectifier K + channels. Clen-induced hyperpolarization of fast-spiking interneurons was dependent on Gs protein rather than cAMP and protein kinase A. Our findings demonstrate that Clen (10 lM) enhances inward rectifier K + channels via Gs protein to cause membrane hyperpolarization of fast-spiking GABAergic interneurons resulting in reduction of action potentials firing rate to reduce GABAergic transmission.
Norepinephrine (NE) plays a key role in the regulation of prefrontal cortex (PFC) cognitive function such as working memory and decision making (Arnsten and Li 2005; Caetano et al. 2012) . It is well known that optimal levels of NE released improve PFC function through the activation of a 2 -adrenoceptors (a 2 -ARs) (Arnsten and Goldman-Rakic 1985; Li et al. 1999; Wang et al. 2007 ). However, higher levels of NE releases cause an adverse effect on PFC function through interaction with a 1 -ARs and/or b 1 -ARs (Arnsten and Jentsch 1997; Ramos et al. 2005) .
b-ARs, which are G protein-coupled receptors, include b 1 , b 2, and b 3 subtypes (Nicholas et al. 1993) . Although behavioral pharmacology studies have revealed that local infusion of b 1 /b 2 antagonist into PFC does not influence working memory function (Li and Mei 1994) , Ramos et al. (2005) reports that endogenous activation of b 1 -ARs produces an adverse effect on PFC cognitive function. Recently, one study reveals that activation of PFC b 2 -ARs by clenbuterol (Clen) improves behavioral memory through the cAMP/protein kinase A (PKA) signaling pathway (Zhou et al. 2013) . However, Schutsky et al. (2011) revealed that stimulation of b 2 -ARs produces a detrimental effect on the retrieval of memory through downstream Gi/o-coupled signaling. Thus, b 2 -ARs appear to achieve differing effects on memory by engaging different downstream signaling mechanisms.
A recent immunohistochemical study has revealed that b 2 -ARs are expressed in a large number of GABAergic interneurons in mouse medial PFC, including parvalbumin-, calbindin D-28k-, calretinin-, somatostatin-, and Reelinimmunoreactive (ir) interneurons (Liu et al. 2014) . Synaptic transmission onto deep layer 5/6 pyramidal neurons that affect PFC neuronal activity plays an important role in cognitive function (Goldman-Rakic 1995; Heidbreder and Groenewegen 2003) . However, the mechanisms in which b 2 -AR alter synaptic transmission within the PFC are not well characterized. Hence, investigation of b 2 -AR-induced synaptic transmission is necessary for further clearing the neural mechanism underlying b 2 -AR-mediated cognitive process. In this study, we explored the effect of b 2 -AR activation on both glutamatergic and GABAergic transmission and its potential mechanism in layer 5/6 pyramidal neurons of rat PFC. Our results demonstrate that Clen (10 lM) reduces GABergic transmission onto layer 5/6 pyramidal neurons of PFC without effects on glutamatergic transmission.
Materials and methods

Preparation of brain slices
Male and female Sprague-Dawley rats (RRID: RGD_5508397) were obtained from SLACCAS, Shanghai, China; 14-23 days of age [post-natal day (P)14-P23] were used in all experiments (Permit Number: 2007-0002) . Rats were randomized into treatment groups using a randomization table. The experiments were conducted according to the guidelines published in the NIH Guide for the Care and Use of Laboratory Animals. All efforts were made to minimize the number of animals used and their suffering.
We prepared slices as we previously described (Luo et al. 2014 (Luo et al. , 2015 . Briefly, the animals were anesthetized with sodium pentobarbital (40 mg/kg, i.p.) prior to decapitation, the brains were immediately removed and placed in ice-cold artificial cerebrospinal fluid containing (in mM) 124 NaCl, 25 NaHCO 3 , 3 KCl, 2 CaCl2, 1.5 MgSO 4 , 0.4 ascorbic acid, and 10 glucose (pH 7.4). Coronal slices (350 lm) were sectioned on a Leica 1000S vibratome (Leica Microsystems, Buffalo Grove, IL, USA). Before recording, slices were incubated at 30°C for 1 h in the above ice-cold artificial cerebral spinal fluid solution for recovery and then maintained at room temperature (25°C).
Electrophysiological recordings
All experiments were performed in whole-cell configuration of patch clamp as we previously described (Luo et al. 2014 (Luo et al. , 2015 . Briefly, Axopatch 200B amplifiers (Molecular Devices, Sunnyvale, CA, USA) were used. Action potential firing and resting membrane potential (RMP) were measured under the current-clamp conditions, while sEPSC, sIPSC, mIPSC, eIPSC, and puff GABA current were measured under the voltage clamp mode. The intracellular solution for measurement of sEPSCs contained (in mM): 150 K + gluconate, 10 HEPES, 8 NaCl, 0.4 EGTA, 2 ATP. Mg, 0.1 GTP.Na +3 , and 10 Na2 phosphocreatine; pH 7.4 (with NaOH). The intracellular solution for measurement of sIPSC, mIPSC, eIPSC contained (in mM): 130 caesium gluconate, 10 HEPES, 8 NaCl, 2 ATP. Mg, 0.4 EGTA, 0.1 GTP.Na +3 and 10 Na2 phosphocreatine; pH 7.4 (with NaOH).
For measurement of sEPSC, GABA A receptor antagonist PTX (100 lM) was bath applied and the holding potential was À70 mV. For measurement of sIPSC, mIPSC, eIPSC, and puff GABA current, NMDA receptor antagonist AP-5 (50 lM) and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist DNQX (20 lM) was bath applied and the holding potential was +30 mV. mIPSC was recorded in the additionally presence of 1 lM tetrodotoxin (TTX). To record puff GABA current, puff pipettes (the same as recording pipettes) were filled with muscimol (50 lM), a GABA A receptor agonist, and positioned a point perpendicular to the cell body of recorded neurons in the extracellular presence of AP-5 (50 lM), DNQX (20 lM) and TTX (1 lM). As interneurons did not exhibit spontaneous action potentials, 800 ms depolarizing current pulses (100-200 pA) were delivered every 30 s, with the current amplitude adjusted for each cell to elicit an average of 20 to 25 action potentials per pulse before bath application of Clen (10 lm). The current intensity that induced 20 action potentials was defined as minimal positive current. Once a stable baseline was established (> 5 min), Clen (10 lm) was bath applied.
Data analysis
Staff members were not blinded to the drug application. Electrophysiology data recorded by clampex (version 9.2.0.09; Axon Instruments, Sunnyvale, CA, USA) were analyzed by clampfit (version 9.2.0.09; Axon Instruments). The paired-pulse facilitation (PPF) was calculated as the mean amplitude of the second synaptic current divide by mean amplitude of first evoked current, and interpulse interval of PPF is 50 ms. Sample size calculation and power analysis were performed using online tools (http://powerandsa mplesize.com/) (power = 0.8, a = 0.05). The specific tests that were used are noted in the results section. When comparing two datasets, Student's t-test was used. When comparing multiple (> 2) groups, one-way ANOVA (repeated measures when appropriate) was used with multiple pairwise comparisons performed using Student-NewmanKeuls test by a GraphPad InStat 3 (GraphPad Software Inc., San Diego, CA, USA). Results are presented as a mean AE standard error of mean (SEM). Statistical significance was assessed at p < 0.05. Asterisks in the figures indicate positive significance levels.
Results
Clen decreases sIPSC frequency without effects on sEPSCs To investigate the role of Clen (10 lM) in the regulation of synaptic transmission onto PFC layer 5/6 pyramidal neurons, we first probed the influence of Clen (10 lM) on glutamatergic transmission through recording sEPSCs with the holding potential at À70 mV. Under this circumstance, bath application of Clen (10 lM) did not influence sEPSC frequency ( Fig. 1a and b , n = 5, control: 3.1 AE 0.3 Hz; Clen: 2.9 AE 0.2 Hz, p > 0.05 vs. control) as well as amplitude ( Fig. 1a and c, n = 6, control: 13.5 AE 0.4 pA; Clen: 13.1 AE 0.3 pA, p > 0.05 vs. control), suggesting Clen (10 lM) does not alter excitatory glutamatergic input onto the PFC layer 5/6 pyramidal neurons.
We next probed the influence of Clen (10 lM) on sIPSCs at the holding potential of +30 mV. Bath application of PTX (100 lM) completely abolished these synaptic currents, suggesting they are mediated by GABAA receptor (data not shown). As shown in Fig. 1(d) , application of Clen (10 lM) decreased sIPSC frequency ( Fig. 1d and e, n = 6, control: 3.2 AE 0.2 Hz; Clen: 2.2 AE 0.2 Hz, p < 0.05 vs. control) with no effects on amplitude ( Fig. 1d and f, n = 6, control: 13.3 AE 0.3 pA; Clen: 13.2 AE 0.4 pA, p > 0.05 vs. control). To confirm that Clen-reduced sIPSC frequency was mediated through b 2 -ARs, antagonist ICI 118551 (10 lM), which is the b 2 -ARs selective, was included in the bath solution 10 min before Clen (10 lM) application. In this condition, Clen (10 lM) did not influence sIPSC frequency (Fig. 1e , n = 6, control: 3.0 AE 0.4 Hz; Clen: 2.8 AE 0.3 Hz, p > 0.05 vs. control).
Clen has no effects on mIPSCs with heterogeneous effects on eIPSCs sIPSCs in the absence of TTX (1 lM) is believed to represent both action potential-dependent and action potential-independent process, whereas mIPSCs represent spontaneous vesicles fusion without involvement of action potential-dependent processes. We next tested mIPSCs induced by Clen (10 lM). Application of Clen (10 lM) changed neither the frequency ( Fig. 2a-c , n = 6, control: 2.7 AE 0.3 Hz; Clen: 2.6 AE 0.2 Hz, p > 0.05 vs. control) nor the amplitude ( Fig. 2a and d , n = 6, control: 12.6 AE 0.4 pA; Clen: 12.5 AE 0.3 pA, p < 0.05 vs. control) of mIPSCs, suggesting that Clen (10 lM) does not influence post-synaptic GABA A receptors. Taken together, our result demonstrate that Clen (10 lM) reduces GABAergic transmission through an action potential-dependent mechanism.
We then studied the influence of Clen (10 lM) on eIPSCs. Of the 12 neurons tested, eight neurons exhibited a decreased effect (Fig. 2e, 75 .1 AE 6.4% of control, p < 0.05 vs. control), four synapses showed no change (Fig. 2f, 98 . 6 AE 7.7% of control, p > 0.05 vs. control). The mechanisms underlying Clen-induced heterogeneity of eIPSCs may be because of the selective expression of b 2 -ARs or other GABA release machineries at the stimulated pre-synaptic GABAergic terminals.
We further used two independent approaches to ensure that pre-synaptic mechanism is involved in Clen-reduced GABAergic transmission. First, we examined the effect of Clen (10 lM) on the eIPSC-mediated PPF. As illustrated in Fig. 3 (a), Clen (10 lM) significantly enhanced the PPF (Fig. 3a , n = 4, control: 1.07 AE 0.06, Clen: 1.33 AE 0.04, p < 0.05 vs. control). Second, we recorded post-synaptic GABA A receptor-mediated currents through puff application and during (right) application of Clen (10 lM) in the co-presence of aamino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist DNQX (20 lM) and NMDA receptor antagonist AP-5 (50 lM). (e) Cumulative distribution of inter-event intervals before and during application of Clen (10 lM). Inset showing summarized data for Clen-induced effect on the sIPSC frequency (n = 6). Clen-reduced sIPSC frequency was blocked by co-administered b 2 -AR-selective antagonist ICI 118551 (10 lM) (n = 6). *p < 0.05 versus control. (f) Cumulative distribution of amplitude from the same neuron before and during application of Clen (10 lM). Inset illustrating summarized data for Clen-induced effect on the sIPSC amplitude (n = 6).
of muscimol (50 lM), a GABA A receptor agonist, from a puff pipette in the extracellular presence of TTX (1 lM), DNQX (20 lM), and AP-5 (50 lM). Muscimol-induced currents were abolished by PTX (100 lM), suggesting that these currents were mediated by post-synaptic GABA A receptor (data not shown). Our result showed that Clen (10 lM) failed to influence the GABA A receptor-mediated currents (Fig. 3b , n = 5, control: 102.3 AE 12.7 pA; Clen: 94.3 AE 15.6 pA, p > 0.05 vs. control), suggesting that Clenreduced GABAergic transmission involves pre-synaptic mechanism.
Clen decreases the excitability of fast-spiking interneurons We then tested the hypothesis that Clen-reduced GABAergic transmission comes from Clen-induced reduction of action potentials in fast-spiking interneurons resulting in a decrease in GABA release. To test this possibility, we investigated the effect of Clen (10 lM) on modulation of fast-spiking interneurons excitability through recording action potentials firing of fast-spiking interneurons. Fastspiking interneurons exhibited a shorter spike half-time, a lower input resistance, and a stronger afterhyperpolarization (AHP) than pyramidal neurons (Table 1) . Because fastspiking interneurons did not burst spontaneous action potentials, action potentials firing was induced via minimal positive current injection. Under such a condition, Clen (10 lM) significantly reduced firing frequency of action potentials (Fig. 4a , n = 6, control: 30.5 AE 2.5 Hz; Clen: 19.4 AE 2.1 Hz, p < 0.05 vs. control).
We then probed the mechanism underlying Clen-induced reduction in firing frequency of action potentials. Given that Clen (10 lM) could increase afterhyperpolarization via decreasing action potentials firing frequency without generating membrane hyperpolarization. We then examined the effects of Clen (10 lM) on AHP amplitude. As illustrated in Fig. 4(b) , Clen (10 lM) did not modulate the amplitude of afterhyperpolarization (Fig. 4b , n = 6, control: 11.1 AE 1.3 mV; Clen: 10.3 AE 0.9 mV, p > 0.05 vs. control). Our result demonstrates that regulation of AHP does not contribute to Clen-induced reduction in firing frequency of action potentials.
We next tested whether Clen (10 lM) decreased firing frequency of action potentials through hyperpolarizing fastspiking interneurons. We recorded Clen-induced change in RMP of fast-spiking interneurons under current-clamp mode. To block potential effect of Clen (10 lM) on synaptic transmission onto fast-spiking interneurons, PTX (100 lM), DNQX (20 lM), AP-5 (50 lM), as well as TTX (1 lM) were added in the extracellular solution. Under such a circumstance, Clen (10 lM) hyperpolarized fast-spiking interneurons (Fig. 4c , n = 5, control: 62.8 AE 0.7 mV; Clen: 67.1 AE 0.6 mV, p < 0.05 vs. control), and reduced input resistance of fast-spiking interneurons (n = 5, control: 158.3 AE 8.2 MΩ, Clen: 117.1 AE 9.8 MΩ, p < 0.05 vs. control).
Kirs are involved in Clen-induced hyperpolarization of fastspiking interneurons
We then probed the potential mechanism of Clen-induced hyperpolarization of fast-spiking interneurons, we first investigated whether Clen (10 lM) hyperpolarizes fastspiking interneurons via inhibiting cationic channels. If that is the case, changes in Na + influx may cause hyperpolarization fast-spiking interneurons. The extracellular NaCl was substituted by the same concentration of NMDG-Cl, as illustrated in Fig. 4(d) , Clen-induced membrane hyperpolarization was similar with control ( Fig. 4d , n = 4, 4.3 AE 0.7 mV, p > 0.05 vs. Clen alone), suggesting that Clen-induced membrane hyperpolarization of fast-spiking interneurons does not require extracellular Na + influx. As our above result revealed that Clen (10 lM) reduces input resistance of fast-spiking interneuron, it is reasonable to presume that Clen (10 lM) causes hyperpolarization of fastspiking interneurons via enhancement of K + channels. To verify this possibility, we replaced intracellular K + -gluconate with NMDG-gluconate. Under such a condition, Cleninduced hyperpolarization of fast-spiking interneurons was blocked (Fig. 5a , n = 4, 0.5 AE 0.4 mV, p < 0.05 vs. Clen alone), suggesting that K + channels is involved in Cleninduced hyperpolarization.
We further characterized the properties of involved K + channels. As RMP could be affected by a variety of K + channels, we first investigated the influence of Clen (10 lM) on RMP of fast-spiking interneuron in the extracellular presence of a classical K + channel blocker tetraethylammonium (10 mM). Under these conditions, Clen-induced hyperpolarization was still observed (Fig. 5b , n = 4, 4.1 AE 0.3 mV, p > 0.05 vs. Clen alone). Because the inward rectifier K + channels (Kirs) are not sensitive to the classical K + channel blockers, we therefore tested the role of Kirs. As shown in Fig. 5(c) , Clen-induced hyperpolarization of fastspiking interneurons was not observed in the intracellular Fig. 3 Clen increases paired-pulse facilitation (PPF) of GABA A receptormediated eIPSCs without effects on currents evoked by puff application of muscimol. (a) Clen (10 lM) increased the PPF of GABA A receptor-mediated evoked IPSCs (n = 4). *p < 0.05 versus control. (b) Clen (10 lM) did not change post-synaptic GABA A receptor-mediated currents evoked by puff application of GABA A receptor agonist muscimol (50 lM) (n = 5). presence of the specific Kirs inhibitor tertiapin-Q (50 nM) (Fig. 5c , n = 4, 0.4 AE 0.3 mV, p < 0.05 vs. Clen alone) and Clen-reduced sIPSC frequency recorded from pyramidal neurons was also abolished (Fig. 5d, 103 . 5 AE 7.1% of control, n = 5, p > 0.05 vs. control), suggesting that Kirs is necessary for Clen-induced hyperpolarization of fast-spiking GABAergic interneurons and Clen-reduced GABAergic transmission.
To investigate the influence of Clen (10 lM) on the IRKC, a ramp protocol (from À110 to À50 mV) to isolate IRKC was used in the presence of DNQX (20 lM), AP-5 (50 lM), PTX (100 lM), TTX (1 lM), Cd 2+ (100 lM), and 100 Ni 2+ (100 lM). As shown in Fig. 5 (e), Cs + (1 mM) abolished these inward currents (Fig. 5e , n = 3), which is same as electrophysiological character of IRKC as described before (Jan and Jan 1997; Dong et al. 2004) . By taking advantage of this protocol, an average value of the change in current induced by Clen (10 lM) was 18.7 AE 2.3% (Fig. 5f , n = 5, p < 0.05 vs. control). More importantly, a strong inward rectification was observed through the voltage-current relationship of Clen-sensitive currents, and had an average reversal potential (Fig. 5f , n = 5, À83.2 AE 1.7 mV), which approximates the calculated K + reversal potential (À84.1 mV).
Signaling mechanisms underlying Clen-reduced GABAergic transmission
We next tested the role of G proteins in Clen-induced hyperpolarization of fast-spiking interneurons because b 2 -ARs are G protein-coupled (Ordway et al. 1987) . NF449 (10 lM), which is a selective Gs protein inhibitor, was included in the bath perfusate to inhibit Gs proteins. Under this circumstance, Clen (10 lM) did not influence RMP of fastspiking interneurons (Fig. 6a, 0 .6 AE 0.4 mV, n = 4, p > 0.05 vs. control) as well as sIPSC frequency (Fig. 6b , n = 5, 96.2 AE 6.5% of control, p > 0.05 vs. control), suggesting Gs proteins are involved in Clen-reduced GABA release.
b 2 -ARs are commonly coupled to the cAMP/PKA-dependent downstream pathways (Ordway et al. 1987 ), then we investigated the effect of Clen (10 lM) on hyperpolarization of fast-spiking interneurons in the presence of cAMP or PKA. As illustrated in Fig. 6(c) , bath application of Rp-cAMPS (10 lM), a selective cAMP inhibitor, did not influence Cleninduced hyperpolarization of fast-spiking interneurons (Fig. 6c , n = 5, 3.9 AE 0.4 mV, p < 0.05 vs. control). In addition, Rp-cAMPS (10 lM) did not abolish Clen-reduced sIPSC frequency (Fig. 6d , n = 5, 72.3 AE 4.8% of control, p < 0.05 vs. control), excluding the involvement of cAMP (10 lM). We finally examined the roles of PKA in Clenmediated hyperpolarization. As shown in Fig. 6 (e), Clen (10 lM) still induced hyperpolarization of fast-spiking interneurons (Fig. 6e , n = 5, 4.4 AE 0.5 mV, p < 0.05 vs. control), and reduced sIPSC frequency (Fig. 6f , n = 5, 68.1 AE 7.1% of control, p < 0.05 vs. control) in the extracellular presence of PKA inhibitor PKI [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] (1 lM), suggesting that the cAMP/PKA-dependent pathway is unnecessary for Clen-induced hyperpolarization of fast-spiking interneurons.
Discussion
Our current work focuses on the role of b 2 -AR in modulating synaptic transmission in PFC layer 5/6 pyramidal neurons. We find that Clen (10 lM) decreases the frequency of sIPSC with no effects on the amplitude. Clen-reduced GABA release is action potential-dependent because Clen (10 lM) does not modulate mIPSC frequency and amplitude. We also find that Clen (10 lM) reduces GABAergic transmission through enhancing Kirs, leading to fast-spiking interneurons hyperpolarization and reduction in action potentials firing rate.
Our electrophysiological result that Clen (10 lM) reduces sIPSC frequency rather than amplitude suggests that a presynaptic mechanism is involved in Clen-reduced GABAergic transmission, probably acting at pre-synaptic b 2 -ARs. Further investigation of b 2 -ARs tagging on fast-spiking GABAergic terminals could ensure our hypothesis. In addition, Clen (10 lM) appears to not modulate the function of GABA A receptor via a post-synaptic mechanism because Clen (10 lM) does not influence the amplitude of sIPSCs and mIPSCs, which is confirmed by the result that Clen (10 lM) does not influence GABA currents by puff GABA A receptor agonist muscimol (50 lM) onto soma of recorded neurons.
We also find that Clen (10 lM) exerts heterogeneous effects on eIPSCs. Bath application of Clen (10 lM) decreased or did not change eIPSC amplitude at individual synapses. Although the precise mechanisms whereby the showing that Clen (10 lM) suppressed IRKC. Lower: The Clengenerated net currents obtained by subtraction of the control from that in the presence of Clen (10 lM) had an average reversal potential at À83.2 mV (n = 5) close to the calculated K + reversal potential (À84.1 mV). Note that the Clen-sensitive currents displayed an inward rectification.
heterogeneous phenomenon of eIPSCs induced through Clen (10 lM) remain unclear, there are several possible reasons for explaining this discrepancy. First, Clen-reduced eIPSC amplitude at synapses may represent the true responses of Clen (10 lM) such as decrease in GABA release. At the stimulated fibers, the pre-synaptic GABAergic terminals express b 2 -ARs and other required GABA release machineries. Second, sIPSCs result from lots of different synapses onto the recorded neurons, whereas eIPSCs are caused via a few fibers that are exogenously stimulated. Clen (10 lM) would have no effects on GABA release if these stimulated fibers do not express b 2 -ARs. This may explain the results that Clen (10 lM) does not influence eIPSC amplitude at some synapses. Although Clen (10 lM) causes heterogeneous effects on eIPSCs through distinct mechanisms, our result that Clen (10 lM) reduces sIPSC frequency in every neuron tested suggests that Clen (10 lM) reduces GABAergic transmission as sIPSCs represent a more natural GABAergic transmission in vivo. Electrically stimulated synaptic responses represents neurotransmitter release from readily releasable vesicle pools. Since Clen (10 lM) induced a decrease in amplitude and an increase in paired-pulse ratio in evoked responses in the majority of cells, this indicates a decrease in the probability of release and thus a change in the readily releasable vesicle pool. Reduction in sIPSC frequency following Clen (10 lM) treatment also indicates a pre-synaptic mechanism and it is likely that this is also because of a decrease in the probability of release. However, it is possible that an alternative mechanism may underlie this change since it has recently been reported that neurotransmitter released during evoked or spontaneous transmission may represent distinct pools of neurotransmitter (Ramirez et al., 2012) . Nevertheless, in both cases, the results indicate that Clen (10 lM) induces a decrease in pre-synaptic GABAergic activity. Several possible mechanisms could be proposed to explain Clen-reduced GABA release. First, Clen (10 lM) could enhance AHP to decrease action potentials firing frequency resulting in Clen-induced decrease in GABA release. However, our data do not support this mechanism because Clen (10 lM) has no effects on AHP of fast-spiking interneurons. Second, Clen (10 lM) could enhance resting K + channels to hyperpolarize fast-spiking GABAergic interneurons, leading to reduction in action potential firing and GABA release. Our result support this mechanism based on the following evidence. First, omission of intracellular K + counteracts Clen-induced fast-spiking interneurons hyperpolarization. Second, Clen-induced net current approximate the K + reversal potential demonstrating that Clen (10 lM) hyperpolarizes fast-spiking interneurons through potentiation of Kirs. Third, both Clen-reduced sIPSC frequency and Cleninduced fast-spiking interneurons hyperpolarization are abolished when the selective Kirs blocker was included in the extracellular solution. In a word, there is reason to speculate that Clen (10 lM) hyperpolarizes the membrane potentials of fast-spiking GABAergic interneurons via potentiation of Kirs, leading to reduced action potentials firing rate of fast-spiking interneurons to decrease GABA release. However, given that change in concentrations of extracellular K + would hyperpolarize all neurons in the slice, further studies are still required for confirming our conclusion by investigating Clen (10 lM) effect by changing the excitability of the slice.
There is evidence that b 2 -ARs are coupled to the cAMP/ PKA-dependent downstream pathway via Gs proteins (Ramos and Arnsten 2007) . Our results have demonstrated that Gs proteins are involved in Clen-mediated decrease in GABA releases. However, our data suggest that intracellular molecules downstream of G protein are not involved in Clenmediated decrease in GABAergic transmission. Although the primary intracellular pathway coupled to b 2 -ARs is believed to be PKA-dependent pathway, our results indicate that PKA is not involved. It is possible that b 2 -ARs activation directly interacts with Kirs to decrease GABA release without PKA.
Although our result suggests that Gs proteins directly couple to Kirs, several reports demonstrate Kir/G protein gated inwardly rectifying K channels (GIRK) is activated by beta/gamma subunits of G proteins (Wellner-Kienitz et al. 2001; Bosche et al. 2003) . Thus, further work is still necessary for a precise understanding of the potential signaling mechanism of Clen-induced effect on GABAergic transmission. For example, recording-connected pairs of fastspiking interneuron-pyramidal neurons would give access to the pre-synaptic neuron and allow direct testing of beta/ gamma dependence of the Clen-induced effect.
Conclusion
Our results demonstrate that Clen (10 lM) reduces GABAergic transmission rather than glutamatergic transmission via stimulation of b 2 -ARs on fast-spiking GABAergic interneurons. b 2 -ARs activation causes membrane hyperpolarization of fast-spiking GABAergic interneurons leading to decreases in action potentials firing rate through potentiation of Kirs. Clen-reduced GABAergic transmission requires Gs proteins rather than cAMP and PKA demonstrating a direct coupling of Gs and Kirs.
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